The research of establishment of therapeutic method and safety in High-Intensity Focused Ultrasound (HIFU) therapy for unresectable pancreatic cancer

The research of establishment of therapeutic method and safety in High-Intensity Focused Ultrasound (HIFU) therapy for unresectable pancreatic cancer - The research of HIFU therapy for unresectable pancreas cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009969

Enrollment

Registered

2013-02-05

Start date

2013-02-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

HIFU equipment:FEP-BY02(China Medical Tecnologies Co.)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: * age >20 years old * WBC > 2000 Plt >5 Cre > 3.0 mg/dl *Normal EKG *PS: 0~3 *Survival time > 4 weeks

Exclusion criteria

Exclusion criteria: *The patients with other malignancy *Pregnancy case *Obstructive Jaundice *The patients with severe heart and brain disease

Design outcomes

Primary

Measure	Time frame
the safety	—

Secondary

Measure	Time frame
the effect and usefulness of therapy	—

Countries

Japan

Contacts

Public ContactAtsushi Sofuni

Tokyo Medical University Gastroenterology and hepatology

a-sofuni@amy.hi-ho.ne.jp03-3342-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026